TMC Life Sciences Berhad Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for TMC Life Sciences Berhad.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 2.4% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly
Feb 14
We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt
Sep 29Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)
Aug 26TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue
May 26TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 09Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)
Jan 13Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?
Dec 22Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?
Dec 02In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat TMC Life Sciences Berhad onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 346 | 41 | 46 | 75 | N/A |
| 3/31/2024 | 357 | 53 | 65 | 100 | N/A |
| 12/31/2023 | 353 | 57 | 68 | 97 | N/A |
| 9/30/2023 | 332 | 48 | 41 | 73 | N/A |
| 6/30/2023 | 312 | 39 | 20 | 55 | N/A |
| 3/31/2023 | 298 | 49 | 3 | 52 | N/A |
| 12/31/2022 | 277 | 42 | -11 | 45 | N/A |
| 9/30/2022 | 263 | 44 | -18 | 52 | N/A |
| 6/30/2022 | 244 | 41 | -33 | 36 | N/A |
| 3/31/2022 | 226 | 22 | -47 | -1 | N/A |
| 12/31/2021 | 213 | 18 | -71 | -1 | N/A |
| 9/30/2021 | 203 | 17 | -87 | -1 | N/A |
| 6/30/2021 | 201 | 20 | -81 | 22 | N/A |
| 6/30/2020 | 184 | 16 | -146 | 18 | N/A |
| 5/31/2020 | 190 | 10 | -139 | 9 | N/A |
| 2/29/2020 | 206 | 22 | -110 | 37 | N/A |
| 11/30/2019 | 200 | 22 | -59 | 49 | N/A |
| 8/31/2019 | 195 | 21 | -31 | 30 | N/A |
| 5/31/2019 | 187 | 33 | -21 | 43 | N/A |
| 2/28/2019 | 180 | 30 | -17 | 30 | N/A |
| 11/30/2018 | 174 | 29 | -11 | 23 | N/A |
| 8/31/2018 | 169 | 28 | -9 | 26 | N/A |
| 5/31/2018 | 165 | 28 | N/A | 16 | N/A |
| 2/28/2018 | 161 | 28 | N/A | 22 | N/A |
| 11/30/2017 | 157 | 28 | N/A | 14 | N/A |
| 8/31/2017 | 152 | 26 | N/A | 10 | N/A |
| 5/31/2017 | 146 | 21 | N/A | 4 | N/A |
| 2/28/2017 | 140 | 20 | N/A | 12 | N/A |
| 11/30/2016 | 136 | 19 | N/A | 16 | N/A |
| 8/31/2016 | 131 | 18 | N/A | 25 | N/A |
| 2/29/2016 | 121 | 13 | N/A | 14 | N/A |
| 11/30/2015 | 116 | 13 | N/A | 18 | N/A |
| 8/31/2015 | 107 | 10 | N/A | 10 | N/A |
| 5/31/2015 | 103 | 10 | N/A | 11 | N/A |
| 2/28/2015 | 98 | 9 | N/A | 16 | N/A |
| 11/30/2014 | 94 | 7 | N/A | 13 | N/A |
| 8/31/2014 | 91 | 8 | N/A | 12 | N/A |
| 5/31/2014 | 86 | 6 | N/A | 12 | N/A |
| 2/28/2014 | 82 | 5 | N/A | 11 | N/A |
| 11/30/2013 | 78 | 3 | N/A | 11 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if TMCLIFE's forecast earnings growth is above the savings rate (3.6%).
Winst versus markt: Insufficient data to determine if TMCLIFE's earnings are forecast to grow faster than the MY market
Hoge groeiwinsten: Insufficient data to determine if TMCLIFE's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if TMCLIFE's revenue is forecast to grow faster than the MY market.
Hoge groei-inkomsten: Insufficient data to determine if TMCLIFE's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if TMCLIFE's Return on Equity is forecast to be high in 3 years time